FACULTY


IMMUNOTHERAPY BRIDGE
December 2nd-3rd, 2020
VIRTUAL MEETING


FACULTY


Sanjiv S. Agarwala
Professor & Chief, Haematology & Oncology, St Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania, US

Rodabe Amaria
Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Paolo A. Ascierto
Director, Medical Oncology, Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute Fondazione "G. Pascale", Naples, Italy

Joshua Brody
Assistant Professor, The Mount Sinai Cancer Center, New York, NY, US

Alfredo Budillon
Director Experimental Pharmacology Unit, Department of Research, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Luigi Buonaguro
Unit of Molecular Biology and Viral Oncology, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Elizabeth M. Burton
Director, Melanoma Research Planning & Development, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Lisa H. Butterfield
Research Center Vice President, Parker Institute for Cancer Immunotherapy and Adjunct Professor of Microbiology and Immunology, University of California, San Francisco, California, US

Tina Cascone
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Fortunato Ciardiello
Professor of Medical Oncology, Director Medical Oncology and Hematology Division, University “Luigi Vanvitelli”, Naples, Italy

Bruno Daniele
Director of Clinical Oncology Unit, Hospital “del Mare”, ASL Napoli 1 Centro, Naples, Italy

Sandra Demaria
Professor of Pathology and Laboratory Medicine, Professor of Radiation Oncology and Adjunct Professor at Department of Pathology, Weill Cornell Medical College and NYU School of Medicine, New York City, New York, US

Leisha Emens
Director of Translational Immunotherapy for the Women’s Cancer Research Center , UPMC Hillman Cancer Center/Magee Women's Hospital, Co-Leader, Hillman Cancer Immunology/Immunotherapy Program, Pittsburgh, Pennsylvania, US

Robert Ferris
UPMC Endowed Professor and Chief, Division of Head and Neck Surgery, Department of Otolaryngolog, University of Pittsburgh, Pennsylvania, US

Silvia Formenti
Chairman of Radiation Oncology - Weill Cornell Medical College, New York City, New York, US

Bernard A. Fox
Chief of Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, Oregon, US

Jerome Galon
Research Director, National Institute of Health and Medical Research (INSERM), Paris, France

Cesare Gridelli
Chief of Division of Medical Oncology, “S.G. Moscati” Hospital, Avellino, Italy

John B. Haanen
Consultant Medical Oncologist, CSO Immunotherapy and Staff Scientist in the Division of Immunology, Professor of Translational Immunotherapy of Cancer, Leiden University Medical Centre, Amsterdam, The Netherlands

Patrick Hwu
Department of Melanoma Medical Oncology, Division of Cancer Medicine, Anderson Cancer Center, Houston, TX, US

Susan Kaech
Director, Nomis Center for Immunobiology and Microbial Pathogenesis, The Salk Institute, University of California, San Francisco, CA, US

Samir N. Khleif
Director of the Loop Immuno-Oncology Laboratory, Biomedical Scholar and Professor of Oncology, Georgetown University Medical School, Washington, DC, US

Tomas Kirchhoff
Associate Professor, Department of Population Health Associate Professor, Department of Environmental Medicine, Perlmutter Cancer Center, New York City, New York, US

Jennifer Mcquade
Assistant Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, US

Adekunle Odunsi
Deputy Director, Exec Director-Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Akash Patnaik
Assistant Professor of Medicine, Hematology and Oncology, Director of Laboratory for Developmental Therapeutics Attending Physician, Genitourinary Oncology Program, The University of Chicago Comprehensive Cancer Center Knapp Center for Biomedical Discovery, Chicago, Illinois, US

Chrystal M. Paulos
Associate Professor and Endowed Peng Chair, Department of Microbiology and Immunology Hollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, South Carolina, US

Francesco Perrone
USC Director, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy

Camillo Porta
Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari “A. Moro” and Division of Oncology, AOU Consorziale Policlinico di Bari, Bari, Italy

Igor Puzanov
Director, Early Phase Clinical Trials Program, Chief of Melanoma, Co-Leader, CCSG Experimental Therapeutics Program, Professor of Oncology, Department of Medicine, Roswell Park Comprehensive Cancer Center, Developmental Therapeutics, Buffalo, NY, US

Dirk Schadendorf
Director Clinic for Dermatology, Essen University Hospital, Essen, Germany

Padmanee Sharma
Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Ryan Sullivan
Hematology-Oncology Dept, Massachusetts General Hospital, Boston, MA, US

Janis M. Taube
Director, Division of Dermatopathology, Professor of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, US

John Timmerman
Professor of Medicine, Division of Hematology-Oncology, David Geffen School of Medicine , UCLA Medical Center, Los Angeles, California, US

-->


For information please contact info@melanomabridge.org